Healthcare & Life Sciences News and Articles

Google News – Biopharma External News

Matinas BioPharma Received Notice of Noncompliance - TradingView

news.google.com · 05 Sep 2026

News External News

New Zealand approves use of party drug MDMA to treat trauma

japantoday.com · 05 Sep 2026

Google News – Pharmaceuticals External News

Ionis partner Novartis announces Lp(a)HORIZON Phase 3 topline results for pelacarsen in patients with elevated Lp(a) and established cardiovascular disease (CVD) - Business Wire

news.google.com · 05 Sep 2026

Google News – Pharmaceuticals External News

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

news.google.com · 05 Sep 2026

Google News – Pharmaceuticals External News

Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch

news.google.com · 05 Sep 2026

Google News – Pharmaceuticals External News

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

news.google.com · 05 Sep 2026

Google News – Pharmaceuticals External News

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - The Manila Times

news.google.com · 05 Sep 2026

Google News – Pharmaceuticals External News

Another ARS Pharma (NASDAQ: SPRY) insider stock sale is coming, with the size now disclosed - Stock Titan

news.google.com · 05 Sep 2026

Google News – Pharmaceuticals External News

Kiniksa sets a live healthcare talk for Sept. 9 - Stock Titan

news.google.com · 05 Sep 2026

Google News – Pharmaceuticals External News

Kiniksa Pharmaceuticals to Present at Wells Fargo 21st Annual Healthcare Conference - GlobeNewswire

news.google.com · 05 Sep 2026

Google News – Pharmaceuticals External News

Tarsus Pharmaceuticals Shares Rise After Closing Alkeus Pharmaceuticals Acquisition - marketscreener.com

news.google.com · 05 Sep 2026

Google News – Pharmaceuticals External News

Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now? - The Motley Fool

news.google.com · 05 Sep 2026

Google News – FDA (biotech/pharma) External News

FDA green light for Zanvastro in Alexander disease - The Pharma Letter

news.google.com · 05 Sep 2026

Google News – Pharmaceuticals External News

Should REC-4881’s Registrational Path Talks Reframe How Investors See Recursion Pharmaceuticals’ (RXRX) AI Platform? - simplywall.st

news.google.com · 05 Sep 2026

Google News – Pharmaceuticals External News

Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now? - Currently.com

news.google.com · 05 Sep 2026

News & Articles

The 90-Day Capability Reset for Healthcare Employers

The Decision Architecture Skill Clinical Research Teams Need

Beta Bionics’ insulin patch pump gets FDA nod

HR must set boundaries as it embraces AI notetakers, experts caution

Staff slept while patient killed at NHS mental health unit

Hong Kong parents urged to vaccinate young children amid rising summer flu cases

PEN-Plus operations manual

Human factors isn’t a checkbox: What FDA’s eSTAR requirements mean for MedTech submissions

Responsible spending starts with timely access, informed choices and more connected care

The future of talent sourcing is more than clicks

The Frontline Signal: Turning Daily Friction Into Better Healthcare Hiring

The Digital Health Interpreter: Making Technology Usable in Care

The Pitt is up for 25 Emmys - but the show's biggest fans are real-life doctors

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Lakeland Community Hospital receives grant to expand rural healthcare access - alreporter.com

Stryker stock falls on slower peripheral vascular, hip sales

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

Matinas BioPharma Received Notice of Noncompliance - TradingView

New Zealand approves use of party drug MDMA to treat trauma

Ionis partner Novartis announces Lp(a)HORIZON Phase 3 topline results for pelacarsen in patients with elevated Lp(a) and established cardiovascular disease (CVD) - Business Wire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - The Manila Times

Another ARS Pharma (NASDAQ: SPRY) insider stock sale is coming, with the size now disclosed - Stock Titan

Kiniksa sets a live healthcare talk for Sept. 9 - Stock Titan

Kiniksa Pharmaceuticals to Present at Wells Fargo 21st Annual Healthcare Conference - GlobeNewswire

Tarsus Pharmaceuticals Shares Rise After Closing Alkeus Pharmaceuticals Acquisition - marketscreener.com

Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now? - The Motley Fool

FDA green light for Zanvastro in Alexander disease - The Pharma Letter

Should REC-4881’s Registrational Path Talks Reframe How Investors See Recursion Pharmaceuticals’ (RXRX) AI Platform? - simplywall.st

Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now? - Currently.com